Cloning and Characterization of an Endolysin LysSA120 as a Potential Staphylococcus Biofilm-Removing Agent
Viruses · 09.06.2026 · 18 (6) · 654
DOI: 10.3390/v18060654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 09.06.2026. Verfasst von Natalia N Golosova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia. Hauptthemen laut MEDLINE: Biofilms, Endopeptidases, Staphylococcus, Staphylococcus Phages. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, The Ministry of Education and Science of the Russian Federation, Ministry of Education and Science.
Abstract (Originalsprache)
Staphylococcus aureus, including methicillin- and vancomycin-resistant variants (MRSA, VRSA), causes infections that are increasingly difficult to treat with conventional antibiotics. One of the approaches to developing new therapeutics to treat staphylococcal infections is the use of bacteriophages specific to these bacteria or the lytic enzymes of such bacteriophages, which are capable of hydrolyzing the cell walls of these bacteria. Phage-encoded endolysins offer an alternative promising class of antimicrobial agents. In this study, LysSA120, a 250-amino-acid endolysin encoded by the S. aureus podophage vB_SauP_120, was cloned, expressed in Escherichia coli, and characterized. The domain organization and tertiary structure of LysSA120 were predicted. Recombinant LysSA120 hydrolyzed cell walls were obtained from S. aureus, S. epidermidis, S. haemolyticus, S. warneri, S. auricularis and S. saprophyticus. It was shown that treatment of S. aureus planktonic cells with endolysin LysSA120 led to reduced viability. Furthermore, LysSA120 could hydrolyze mature biofilm formed by VRSA. The lytic spectrum and antibiofilm activity of LysSA120 warrant its further evaluation as an enzybiotic against drug-resistant staphylococcal infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
ORCID-Profile: Yana A Khlusevich, Bogdana I Kravchuk, Lyudmila A Emelyanova, Andrey L Matveev
Förderung
- Russian Science Foundation
- The Ministry of Education and Science of the Russian Federation
- Ministry of Education and Science
Zitieren
APA
Golosova, N. N., Khlusevich, Y. A., Kravchuk, B. I., Emelyanova, L. A., Sushko, A. V., Kozlova, Y. N., Tikunova, N. V., & Matveev, A. L. (2026). Cloning and Characterization of an Endolysin LysSA120 as a Potential Staphylococcus Biofilm-Removing Agent. Viruses, 18(6), 654. https://doi.org/10.3390/v18060654
Vancouver
Golosova NN, Khlusevich YA, Kravchuk BI, Emelyanova LA, Sushko AV, Kozlova YN, et al. Cloning and Characterization of an Endolysin LysSA120 as a Potential Staphylococcus Biofilm-Removing Agent. Viruses. 2026;18(6):654. doi:10.3390/v18060654
BibTeX
@article{Golosova2026,
author = {Golosova, Natalia N and Khlusevich, Yana A and Kravchuk, Bogdana I and Emelyanova, Lyudmila A and Sushko, Anna V and Kozlova, Yulia N and Tikunova, Nina V and Matveev, Andrey L},
title = {Cloning and Characterization of an Endolysin LysSA120 as a Potential Staphylococcus Biofilm-Removing Agent},
journal = {Viruses},
year = {2026},
volume = {18},
number = {6},
pages = {654},
doi = {10.3390/v18060654}
}
EUVIMED